FIRST AMENDMENT TO SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • May 3rd, 2018 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 3rd, 2018 Company IndustryThis FIRST AMENDMENT TO SPONSORED RESEARCH AGREEMENT (the “Amendment”) is entered into effective as of May 28, 2009 (“Amendment Date”), by and between AVI BioPharma, Inc., an Oregon corporation having offices at 4575 SW Research Way, Suite 200, Corvallis, OR 97333 (the “Company”), and Charley's Fund, Inc., a 501(c)(3) tax-exempt public non-profit organization with a mailing address of P.O. Box 297, South Egremont, MA 01258 (the “Sponsor”) (each a “Party” and together the “Parties”), and amends that certain SPONSORED RESEARCH AGREEMENT, effective as of October 12, 2007, by and between the Parties (the “Agreement”), as follows.
SEVENTH AMENDMENT TO LEASELease • May 3rd, 2018 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 3rd, 2018 Company IndustryTHIS SEVENTH AMENDMENT TO LEASE (this “Seventh Amendment”) is made as of April 27, 2018, by and between ARE-MA REGION NO. 38, LLC, a Delaware limited liability company (“Landlord”), and SAREPTA THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
GENERAL RELEASE AND AMENDMENT TO SEPARATION AGREEMENTSeparation Agreement • May 3rd, 2018 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 3rd, 2018 Company IndustryGENERAL RELEASE AND AMENDMENT TO SEPARATION AGREEMENT (the “Release/Amendment”), by Dr. Catherine Stehman-Breen, M.D., M.S. (the “Executive”) in favor of Sarepta Therapeutics, Inc. (the “Company”) and the Company Releasees (as hereinafter defined), dated as of December 15, 2017.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • May 3rd, 2018 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 3rd, 2018 Company Industry JurisdictionTHIS SPONSORED RESEARCH AGREEMENT (this "Agreement"), effective the 12th day of October, 2007 (the "Effective Date"), is entered into by and between AVI BIOPHARMA, INC., an Oregon Corporation, with principal offices located at One SW Columbia, Suite 1105, Portland, Oregon 97258 ("Company"), and CHARLEY'S FUND, INC., a 501(c)(3) tax-exempt public non-profit organization with a mailing address of P.O. Box 297, South Egremont, MA, 01258 (the "Sponsor").